Patient-Reported Quality of Life in Patients With an Implantable-Cardioverter Defibrillator - A Cross-Sectional Observational Study

Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · Oct 21, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how having an Implantable Cardioverter Defibrillator (ICD) affects the quality of life for patients. An ICD is a device that helps prevent life-threatening heart problems by monitoring the heart and delivering shocks if necessary. While this device can save lives, it may also bring challenges that impact how patients feel physically and emotionally. The study aims to gather information directly from patients about their experiences, including how they feel about their health, their acceptance of the device, and any concerns they have regarding their physical and sexual activities.

To participate in this study, you need to be at least 18 years old and have any type of ICD while being treated at UZ Leuven. You should also be able to give your consent to join the study. However, if you are currently hospitalized, have a mental disability, or are part of another interventional study, you won't be eligible. Participants in this study will share their thoughts and feelings, helping researchers understand the real-life impact of living with an ICD. This valuable information can help improve care and support for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years of age
• • Patients with any type of ICD followed in UZ Leuven
• • Willing and able to provide signed written informed consent
• Exclusion Criteria:
• • Patients who are hospitalized
• • Patients with a mental disability
• • Patients already included in another interventional study